RAD001 Shows Potential to Reverse Resistance to Herceptin®* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

RAD001 Shows Potential to Reverse Resistance to Herceptin®* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

Dec 12, 2008
Source URL: https://prod1.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0

List of links present in page
  1. https://prod1.novartis.com/us-en/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0